A study of cells from 84 brains finds that Alzheimer’s has two distinct phases, and that one type of neuron is especially ...

Study finds mosaicism in Down syndrome reduces Alzheimer's risk, providing new insights into genetic influences on cognitive ...

Stem cells grown in microgravity aboard the International Space Station (ISS) are showing potential to transform treatments ...

A new study has used powerful imaging to reveal a subset of Alzheimer's-associated proteins spreading particularly rapidly.

Dementia, a cognitive disorder affecting memory, reasoning, and social abilities, is currently experienced by an estimated 50 ...

Hallucinations are a fairly common symptom in the advanced stages of Alzheimer’s disease. Treatment options like medications or therapy can help reduce their frequency and effect. Alzheimer’s ...

Alzheimer’s disease may cause cognitive complications like severe memory loss, mental health complications like depression, and physical complications like reduced mobility. Alzheimer’s ...

Reddy is a health policy fellow and neurologist at the University of California, San Francisco. Yaffe is the vice chair of psychiatry, neurology, and epidemiology at UCSF and the director of the ...

A new study by researchers at Florida State University's Gut Biome Lab has revealed a potential link between an infection caused by gut bacteria and the progression of Alzheimer's disease.

What is glycogen storage disease in children? Glycogen storage disease (GSD) is a rare condition that changes the way the body uses and stores glycogen, a form of sugar or glucose. Glycogen is a main ...

The most effective drug for Alzheimer’s has been blocked for use on the NHS. Regulators have declared the new treatment for the disease safe for use but the rationing body has immediately ruled ...

Today 23 rd October 2024, the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has licensed a second drug that can slow down Alzheimer’s disease, called donanemab. This means that the ...